Hereditary thrombophilia and venous thromboembolism: critical evaluation of the clinical implications of screening.
Venous thromboembolism is a complex disease resulting from the interactions of several risk factors from diverse origins: genetic, environmental and behavioral. Numerous studies have evidenced an association between genetic thrombophilia defects and venous thromboembolism. However, the clinical relevance of genetic thrombophilia to recurrent venous thromboembolism is not clear and the risks of long-term anticoagulant treatment usually outweigh any benefits of hereditary thrombophilia screening. Therefore, in everyday clinical practice (outside of research protocols) hereditary thrombophilia screening should be performed only in cases where such testing is likely to influence patient management.
Mazzolai
L
L
Service of Angiology, Department of Medicine, CHUV, Lausanne University Hospital, Lausanne, Switzerland. lucia.mazzolai@chuv.ch
Duchosal
M A
MA
D000925:Anticoagulants / Q000627:therapeutic use; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing; D006801:Humans; D012008:Recurrence; D018570:Risk Assessment; D013923:Thromboembolism / Q000209:etiology* / Q000517:prevention & control; D019851:Thrombophilia / Q000235:genetics*; D020246:Venous Thrombosis / Q000209:etiology* / Q000517:prevention & control
D000925:Anticoagulants